Expression of Inhibitor of Growth 4 by HSV1716 Improves Oncolytic Potency and Enhances Efficacy

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2012.24
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

GALV Expression Enhances the Therapeutic Efficacy of an Oncolytic Adenovirus by Inducing Cell Fusion and Enhancing Virus Distribution

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune Checkpoint Blockade

Clinical Cancer Research
Cancer ResearchOncology
2018English

RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth

PLoS ONE
Multidisciplinary
2012English

Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis

Frontiers in Oncology
Cancer ResearchOncology
2016English

Bioselection of a Gain of Function Mutation That Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency

Cancer Research
Cancer ResearchOncology
2008English

Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach

PLoS ONE
Multidisciplinary
2017English

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Response

Clinical Cancer Research
Cancer ResearchOncology
2016English

Expression of Immunomodulatory Neutrophil-Activating Protein of Helicobacter Pylori Enhances the Antitumor Activity of Oncolytic Measles Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

TrkB Inhibition by GNF-4256 Slows Growth and Enhances Chemotherapeutic Efficacy in Neuroblastoma Xenografts

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy